Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Submitted by
admin
on February 17, 2013 - 11:58am
Source:
Pipeline Review
News Tags:
PSMA ADC
prostate cancer
Progenics Pharmaceuticals
Headline:
Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Do Not Allow Advertisers to Use My Personal information
